Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Pheochromocytoma

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Pheochromocytoma

Puneet K. Gupta et al.
Free Books & Documents

Excerpt

A pheochromocytoma is a rare tumor originating from chromaffin cells in the adrenal medulla. Pheotochromocytomas clinical manifestations result from excessive catecholamine secretion. Catecholamines are a group of hormones and neurotransmitters crucial for regulating homeostasis and managing the body's response to stress. These chemicals are primarily produced by the adrenal gland and nerve tissue, including the brain. The principal catecholamines are dopamine, norepinephrine, and epinephrine.

Pheochromocytoma is a neoplasm that can be either benign or malignant and is often associated with familial syndromes such as neurofibromatosis type 1 (NF1), multiple endocrine neoplasia type 2 (MEN2), and von Hippel-Lindau (VHL) disease. In addition, sporadic cases are also significant, as they are among the most commonly overlooked causes of secondary hypertension (see Image. Gross Specimen of a Giant Pheochromocytoma).

The clinical manifestations of these tumors are primarily due to the excessive secretion of catecholamines. Tumors that arise from extra-adrenal chromaffin cells are known as paragangliomas, and both types are often studied together as neuroendocrine tumors due to their similar characteristics. Pheochromocytomas account for 80% to 85% of these tumors, while sympathetic paragangliomas account for 15% to 20%. Although most pheochromocytomas are benign, a small percentage can be malignant.

In the past, pheochromocytomas were primarily identified during evaluations for secondary hypertension. However, they are now increasingly found as incidental findings on abdominal imaging conducted for other conditions or through surveillance screening in individuals with known genetic disorders.

Pheochromocytomas generally exhibit a predominant type of catecholamine production. Around half primarily secrete epinephrine with varying levels of norepinephrine. Others, including sympathetic paragangliomas, mainly produce norepinephrine with dopamine as a by-product. Dopamine production is considered an independent predictor of malignancy, likely due to its role in promoting angiogenesis.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Puneet Gupta declares no relevant financial relationships with ineligible companies.

Disclosure: Bharat Marwaha declares no relevant financial relationships with ineligible companies.

References

    1. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF, Endocrine Society Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42. - PubMed
    1. Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers HJLM, Castinetti F, Dralle H, Widimský J, Gimenez-Roqueplo AP, Eisenhofer G. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens. 2020 Aug;38(8):1443-1456. - PMC - PubMed
    1. Plouin PF, Chatellier G, Fofol I, Corvol P. Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension. 1997 May;29(5):1133-9. - PubMed
    1. Osinga TE, Links TP, Dullaart RPF, Pacak K, van der Horst-Schrivers ANA, Kerstens MN, Kema IP. Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma. FASEB J. 2017 Jun;31(6):2226-2240. - PMC - PubMed
    1. Neumann HP, Young WF, Krauss T, Bayley JP, Schiavi F, Opocher G, Boedeker CC, Tirosh A, Castinetti F, Ruf J, Beltsevich D, Walz M, Groeben HT, von Dobschuetz E, Gimm O, Wohllk N, Pfeifer M, Lourenço DM, Peczkowska M, Patocs A, Ngeow J, Makay Ö, Shah NS, Tischler A, Leijon H, Pennelli G, Villar Gómez de Las Heras K, Links TP, Bausch B, Eng C. 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocr Relat Cancer. 2018 Aug;25(8):T201-T219. - PubMed

Publication types

LinkOut - more resources